BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31724508)

  • 1. Melatonin: Implications for Ocular Disease and Therapeutic Potential.
    Scuderi L; Davinelli S; Iodice CM; Bartollino S; Scapagnini G; Costagliola C; Scuderi G
    Curr Pharm Des; 2019; 25(39):4185-4191. PubMed ID: 31724508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis.
    Rosenstein RE; Pandi-Perumal SR; Srinivasan V; Spence DW; Brown GM; Cardinali DP
    J Pineal Res; 2010 Aug; 49(1):1-13. PubMed ID: 20492443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and therapeutic potential of melatonin in age-related ocular diseases.
    Crooke A; Huete-Toral F; Colligris B; Pintor J
    J Pineal Res; 2017 Sep; 63(2):. PubMed ID: 28658514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Clinical, Pharmacological, and Formulation Evaluation of Melatonin in the Treatment of Ocular Disorders-A Systematic Review.
    Romeo A; Kazsoki A; Musumeci T; Zelkó R
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin in the eye: implications for glaucoma.
    Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP; Rosenstein RE
    Exp Eye Res; 2007 Jun; 84(6):1021-30. PubMed ID: 17174303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular disorders and the utility of animal models in the discovery of melatoninergic drugs with therapeutic potential.
    Crooke A; Huete-Toral F; Martínez-Águila A; Colligris B; Pintor J
    Expert Opin Drug Discov; 2012 Oct; 7(10):989-1001. PubMed ID: 22860991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of melatonin in experimental free radical-related ocular diseases.
    Siu AW; Maldonado M; Sanchez-Hidalgo M; Tan DX; Reiter RJ
    J Pineal Res; 2006 Mar; 40(2):101-9. PubMed ID: 16441546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role and Therapeutic Potential of Melatonin in Degenerative Fundus Diseases: Diabetes Retinopathy and Age-Related Macular Degeneration.
    Ma C; Li H; Lu S; Li X
    Drug Des Devel Ther; 2024; 18():2329-2346. PubMed ID: 38911030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Therapeutic Trip of Melatonin Eye Drops: From the Ocular Surface to the Retina.
    Rusciano D; Russo C
    Pharmaceuticals (Basel); 2024 Mar; 17(4):. PubMed ID: 38675402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of melatonin in the eye and ocular dysfunctions.
    Lundmark PO; Pandi-Perumal SR; Srinivasan V; Cardinali DP
    Vis Neurosci; 2006; 23(6):853-62. PubMed ID: 17266777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular and systemic melatonin and the influence of light exposure.
    Ostrin LA
    Clin Exp Optom; 2019 Mar; 102(2):99-108. PubMed ID: 30074278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin: Unveiling the functions and implications in ocular health.
    Zhang J; Zhou H; Cai Y; Yoshida S; Li Y; Zhou Y
    Pharmacol Res; 2024 Jul; 205():107253. PubMed ID: 38862072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light, dark, and melatonin: emerging evidence for the importance of melatonin in ocular physiology.
    Brennan R; Jan JE; Lyons CJ
    Eye (Lond); 2007 Jul; 21(7):901-8. PubMed ID: 17001324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human pineal gland and melatonin in aging and Alzheimer's disease.
    Wu YH; Swaab DF
    J Pineal Res; 2005 Apr; 38(3):145-52. PubMed ID: 15725334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pineal function during aging: attenuation of the melatonin rhythm and its neurobiological consequences.
    Reiter RJ
    Acta Neurobiol Exp (Wars); 1994; 54 Suppl():31-9. PubMed ID: 7801790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxygen radical detoxification processes during aging: the functional importance of melatonin.
    Reiter RJ
    Aging (Milano); 1995 Oct; 7(5):340-51. PubMed ID: 8719600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melatonin as a Therapeutic Resource for Inflammatory Visual Diseases.
    Aranda ML; Fleitas MFG; Dieguez H; Iaquinandi A; Sande PH; Dorfman D; Rosenstein RE
    Curr Neuropharmacol; 2017; 15(7):951-962. PubMed ID: 28088912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the Gut-Eye Axis: An Emerging Strategy to Face Ocular Diseases.
    Campagnoli LIM; Varesi A; Barbieri A; Marchesi N; Pascale A
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization and biological activities of melatonin in intact and diseased gastrointestinal tract (GIT).
    Konturek SJ; Konturek PC; Brzozowska I; Pawlik M; Sliwowski Z; Cześnikiewicz-Guzik M; Kwiecień S; Brzozowski T; Bubenik GA; Pawlik WW
    J Physiol Pharmacol; 2007 Sep; 58(3):381-405. PubMed ID: 17928638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian rhythms in the eye: the physiological significance of melatonin receptors in ocular tissues.
    Wiechmann AF; Summers JA
    Prog Retin Eye Res; 2008 Mar; 27(2):137-60. PubMed ID: 18316227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.